Application of Radiation Technologies for Quality Improvement of LEDs Based upon AlGaAs

The investigation results of the radiation resistance and reliability of light-emitting diodes (LEDs) based upon AlGaAs are presented. The radiation model and the reliability model are described for LEDs. Preliminary irradiation by gamma-quanta and fast neutrons makes it possible to improve the radiation resistance and reliability of the LEDs during further operation. Based on the developed models, radiation technologies are proposed, and the use of which allows increasing the service properties of the LEDs. The suggested technologies can be used for other types of semiconductor devices

Field Research of Firing Stored Peat Critical Conditions

This paper presents field research: influence of different factors on peat massif firing with local outside heat source. Minimum temperatures of defined size heat source which fires the peat under the wide range of moisture value and heat-exchange conditions with terrestrial environment were found. Besides, peat massif moisture values whereby no firing is undergoing within the range of the researched temperatures of ignition source were defined

Power plant ash and slag waste management technological direction when Kansk-Achinsk brown coal is burned

Today resource efficiency technology development in all industries where conventional raw material is being replaced by local natural resources and industrial waste is an essential matter. Along with that most producing operations are overload with wide range of waste produced during technological process. Thermal power stations are real world evidence. Their main waste is ash and slag which accumulated in great amounts in often overfull ash dumps. The goal of present work is to find perspective ash dump waste utilization methods. The study will be based on experimentally obtained data: elementary compound and properties of Kansk-Achinsk brown coal. Research methods: experimental, chemical silicate analysis, mineralogical forms identification within samples by using ASM X-ray diffraction analysis. Experiments resulted with the following conclusions: silica is ash main component, and ash has the form of ore concentrate analogy in a number of elements. We think that ASM main properties which make it useful for utilization are: high content of calcium oxide; high ash sorption properties; ASM radiation safety class which makes them safe to be used in materials, goods, and structures production for residence and public buildings construction and reconstruction; sufficiently high content of individual elements

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study

Background. Immunological potency of 13-valent pneumococcal vaccine (PCV-13) in children with systemic juvenile idiopathic arthritis (SJIA) is still unstudied. Estimates of the genetically engineered biologic drugs (GEBD) effects on pneumococcal vaccination results also remain controversial.Objective. The aim of the study was to explore the PCV-13 efficacy in patients with SJIA and who is on treatment with monoclonal antibodies against interleukin 6 receptor (tocilizumab) and interleukin 8 receptor beta (canakinumab).Methods. The study included patients under the age of 18 with SJIA in remission or active form of disease vaccinated with PCV-13. The vaccine was administered in single dose of 0.5 ml intramuscularly in patients on treatment with GEBD or 3 weeks before GEBD administration for the first time (for patients with active disease). Vaccination was considered effective at achievement of the minimum protective level of antibodies to capsular polysaccharide of pneumococcus (anti-SPP IgG; ≥ 7 U/ml) or increase of anti-SPP IgG level ≥ 2 times in 4 weeks after vaccination. The anti-SPP IgG levels were measured with enzyme immunoassay.Results. The study included 53 patients (27 girls) in remission of SJIA and 25 (16 girls) in active disease. Median age was 13.3 and 10.8 years respectively. Tocilizumab/canakinumab was administrated in 43/10 and 18/7 patients respectively. Minimum significant anti-SPP IgG level and two-fold increase in anti-SPP IgG level were recorded in 49/53 (92%) and 32/53 (60%) patients with SJIA in remission, as well as in 22/25 (88%) and 18/25 (72%) patients in active disease respectively. PCV-13 immunological potency in patients with SJIA in remission and in active disease (in those who were initially administrated and who did not receive GEBD) did not differ.Conclusion. PCV-13 vaccination allows to achieve protective antibodies level in most of the patients with SJIA in children population regardless of the disease stage and the history of GEBD administration